Alpha Tau Medical Statistics
Total Valuation
DRTS has a market cap or net worth of $156.63 million. The enterprise value is $98.16 million.
Important Dates
The next estimated earnings date is Thursday, November 14, 2024, after market close.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
DRTS has 69.92 million shares outstanding. The number of shares has increased by 0.70% in one year.
| Shares Outstanding | 69.92M |
| Shares Change (YoY) | +0.70% |
| Shares Change (QoQ) | +0.22% |
| Owned by Insiders (%) | 21.98% |
| Owned by Institutions (%) | 5.52% |
| Float | 52.00M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.12 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.66, with a Debt / Equity ratio of 0.17.
| Current Ratio | 11.66 |
| Quick Ratio | 11.00 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -160.82 |
Financial Efficiency
Return on equity (ROE) is -33.17% and return on invested capital (ROIC) is -24.50%.
| Return on Equity (ROE) | -33.17% |
| Return on Assets (ROA) | -21.92% |
| Return on Capital (ROIC) | -24.50% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$228,322 |
| Employee Count | 121 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -27,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -30.00% in the last 52 weeks. The beta is 0.77, so DRTS's price volatility has been lower than the market average.
| Beta (5Y) | 0.77 |
| 52-Week Price Change | -30.00% |
| 50-Day Moving Average | 2.29 |
| 200-Day Moving Average | 2.53 |
| Relative Strength Index (RSI) | 48.26 |
| Average Volume (20 Days) | 23,117 |
Short Selling Information
The latest short interest is 51,404, so 0.07% of the outstanding shares have been sold short.
| Short Interest | 51,404 |
| Short Previous Month | 43,565 |
| Short % of Shares Out | 0.07% |
| Short % of Float | 0.10% |
| Short Ratio (days to cover) | 2.00 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -36.35M |
| Pretax Income | -29.14M |
| Net Income | -27.63M |
| EBITDA | -35.22M |
| EBIT | -36.35M |
| Earnings Per Share (EPS) | -$0.40 |
Full Income StatementBalance Sheet
The company has $71.03 million in cash and $12.56 million in debt, giving a net cash position of $58.47 million or $0.84 per share.
| Cash & Cash Equivalents | 71.03M |
| Total Debt | 12.56M |
| Net Cash | 58.47M |
| Net Cash Per Share | $0.84 |
| Equity (Book Value) | 74.02M |
| Book Value Per Share | 1.06 |
| Working Capital | 68.79M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$20.84 million and capital expenditures -$5.93 million, giving a free cash flow of -$26.77 million.
| Operating Cash Flow | -20.84M |
| Capital Expenditures | -5.93M |
| Free Cash Flow | -26.77M |
| FCF Per Share | -$0.38 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |